‘Charlotte’s Web’ cannabis oil is set to be sold legally in the UK for the very first time.
The product has been the subject of medical and political debate since its emergence in America and is considered, by many, as an alternative treatment for conditions such as epilepsy.
Now a Kent and London-based company, UK CBD, has become the first to sell it in Britain since it was made legal in July this year.
The product is named after Charlotte Fiji, an eight-year-old sufferer of Dravet Syndrome, a severe form of epilepsy.
The improvement in her condition – following her first dose of medical marijuana aged five – led to her being dubbed “the girl who is changing medical marijuana laws across America.”
Charlotte’s case, and others similar to it, led to widespread publicity, including several television documentaries, and the gradual shifting of public opinion in favour of legislation.
“As the leaders in the UK CBD market we are extremely proud to partner with CW Botanicals and to legally add their exclusive Charlotte’s Web products to our already impressive range,” said UK CBD owner and CEO Nicolas P Ellis.
“Their passion and dedication to making such high quality products is already well known globally.”
The strain of cannabis – often known as hemp – does not produce the ‘high’ effect associated with smoking marijuana, but can, according to its supporters, treat disease and improve symptoms.
“We believe that introducing these products to the UK market will help many people suffering from ECS (endocannabinoid system) deficiencies or for those who just wish to add these nutritious cannabinoids to their daily, dietary supplementation,” said Ellis. “Hemp is also rich in vitamins, minerals and omegas 3 & 6.”
(Picture credit: UK CBD)